| Literature DB >> 21873605 |
Annelie Pichert1, Sergey A Samsonov, Stephan Theisgen, Lars Thomas, Lars Baumann, Jürgen Schiller, Annette G Beck-Sickinger, Daniel Huster, M Teresa Pisabarro.
Abstract
The interactions between glycosaminoglycans (GAGs), important components of the extracellular matrix, and proteins such as growth factors and chemokines play critical roles in cellular regulation processes. Therefore, the design of GAG derivatives for the development of innovative materials with bio-like properties in terms of their interaction with regulatory proteins is of great interest for tissue engineering and regenerative medicine. Previous work on the chemokine interleukin-8 (IL-8) has focused on its interaction with heparin and heparan sulfate, which regulate chemokine function. However, the extracellular matrix contains other GAGs, such as hyaluronic acid (HA), dermatan sulfate (DS) and chondroitin sulfate (CS), which have so far not been characterized in terms of their distinct molecular recognition properties towards IL-8 in relation to their length and sulfation patterns. NMR and molecular modeling have been in great part the methods of choice to study the structural and recognition properties of GAGs and their protein complexes. However, separately these methods have challenges to cope with the high degree of similarity and flexibility that GAGs exhibit. In this work, we combine fluorescence spectroscopy, NMR experiments, docking and molecular dynamics simulations to study the configurational and recognition properties of IL-8 towards a series of HA and CS derivatives and DS. We analyze the effects of GAG length and sulfation patterns in binding strength and specificity, and the influence of GAG binding on IL-8 dimer formation. Our results highlight the importance of combining experimental and theoretical approaches to obtain a better understanding of the molecular recognition properties of GAG-protein systems.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21873605 PMCID: PMC3230280 DOI: 10.1093/glycob/cwr120
Source DB: PubMed Journal: Glycobiology ISSN: 0959-6658 Impact factor: 4.313
Fig. 1.Chemical structures of the different types of GAGs used in this study. The repeating disaccharide units of hyaluronan (HA), dermatan sulfate (DS), chondroitin-4-sulfate (CS4) and chondroitin-6-sulfate (CS6) are shown.
Fig. 2.Fluorescence titration curves of IL-8 (1 µM) with HA (squares), DS (inverted triangles), CS4 (triangles) and CS6 (circles). The lines represent fits to the theoretical binding model as described in the text.
Fig. 3.1H-15N HSQC NMR spectra of 15N-labeled IL-8 (1.0 mM, pH 7.0) in the presence of varying concentrations of CS6 hexasaccharide. Each color corresponds to a titration step: black, 0 µM CS6; yellow, 124 µM CS6; red, 244 µM CS6; green, 359 µM CS6; and blue, 471 µM CS6. (A–D) Enlargement of the response of IL-8 residue E75 on titration with various GAGs. (A) IL-8 (0.6 mM) titrated with HA hexasaccharides (black, 0 µM HA; yellow, 86 µM HA; red, 252 µM HA; green, 412 µM HA; blue, 566 µM HA); (B) IL-8 (0.8 mM) titrated with CS4 hexasaccharides (black, 0 µM CS4; yellow, 132 µM CS4; red, 261 µM CS4; green, 389 µM CS4; blue, 541 µM CS4) and (C) IL-8 (1.0 mM) titrated with CS6 hexasaccharides (black, 0 µM CS6; yellow, 124 µM CS6; red, 244 µM CS6; green, 359 µM CS6; blue, 471 µM CS6). (D) IL-8 (1.0 mM) titrated with DS hexasaccharide (black, 0 µM DS; yellow, 117 µM DS; red, 277 µM DS; green, 468 µM DS; blue 637 µM DS).
Fig. 4.Weighted chemical shift perturbation plots of IL-8 showing the chemical shift changes of each residue after titration with (A) 663 µM CS4, (B) 471 µM CS6 and (C) 637 µM DS.
Docking results of tetrasaccharide derivatives of hyaluronan and CS, DS and heparin
| Ligand | Receptor without water molecules | Receptor with 24 water molecules | ||
|---|---|---|---|---|
| Cluster number (members)a | Pose in top 10b | Cluster number (members)a | Pose in top 10b | |
| HA | 1 (14) | 7 | 2 (14) | 8 |
| HA4 | 1 (5) | 7 | 1 (6) | 6 |
| HA6 | 6 (6) | 6 | 6 (2) | 4 |
| HA46 | 1 (4) | 5 | 1 (3) | 7 |
| HA462′ | 2 (4) | 4 | 1 (2) | 8 |
| HA463′ | 6 (1) | 4 | 1 (5) | 6 |
| HA462′3′ | 1 (1) | 3 | 1 (2) | 5 |
| CS_de | 9 (1) | 2 | 7 (2) | 1 |
| CS4 | 2 (1) | 4 | 10 (1) | 2 |
| CS6 | 3 (3) | 4 | 2 (2) | 3 |
| CS46 | 5 (4) | 2 | 4 (2) | 2 |
| CS462′ | 8 (3) | 2 | 7 (2) | 1 |
| CS463′ | 2 (1) | 6 | 3 (3) | 6 |
| CS462′3′ | 3 (2) | 2 | 3 (3) | 2 |
| DSc | 2 (7) | 5 | 1 (6) | 8 |
| Heparinc | 5 (2) | 5 | 4 (1) | 4 |
aCluster rank with the number of cluster members, clustering is done for the RMSD value of 4 Å for GAGs heavy atoms.
bNumber of “correct” poses in the top 10 docking solutions by visual inspection.
cIn DS and heparin the iduronic acid was in .
Fig. 5.(A) MM-PBSA binding free energies for monomeric IL-8 with different tetrameric GAGs in calculated binding pose. Black diamonds and red circles correspond to MD simulations carried out with harmonically constrained IL-8 backbone and free IL-8, respectively. (B) MM-GBSA binding free energies for monomeric IL-8 per residue obtained from 28 MD simulations with different tetrasaccharides of HA and CS derivatives.
Fig. 6.(A) CS6 hexasaccharide (in sticks colored by atom type) in the highly scored binding pose with a monomeric IL-8 (in cartoon in gray). (B) The backbones of the 10 residues with the highest changes of backbone chemical shifts when binding a CS6 hexasaccharide (highlighted in red), and the side chains of the 10 residues with the highest absolute impact for binding according to MM-PBSA free energy decomposition (in sticks in yellow). (C) IL-8 dimer (in cartoon in gray) in complex with the hexasaccharide of CS6 in the “alternative” binding pose (in sticks colored by atom type). Glutamate residues located near the bound GAG are shown in sticks and labeled.
GAG nomenclature and abbreviations for hyaluronan and CS derivatives
| Hyaluronan derivatives | CS derivatives | ||
|---|---|---|---|
| HA | (-GlcUAβ1-3GlcNAcβ1-) | CSde | (-GlcUAβ1-3GalNAcβ1-) |
| HA4 | (-GlcUAβ1-3GlcNAc(4S)β1-) | CS4 | (-GlcUAβ1-3GalNAc(4S)β1-) |
| HA6 | (-GlcUAβ1-3GlcNAc(6S)β1-) | CS6 | (-GlcUAβ1-3GalNAc(6S)β1-) |
| HA46 | (-GlcUAβ1-3GlcNAc(4S,6S)β1-) | CS46 | (-GlcUAβ1-3GalNAc(4S,6S)β1-) |
| HA462′ | (-GlcUA(2′S)β1-3GlcNAc(4S,6S)β1-) | CS462′ | (-GlcUA(2′S)β1-3GalNAc(4S,6S)β1-) |
| HA463′ | (-GlcUA(3′S)β1-3GlcNAc(4S,6S)β1-) | CS463′ | (-GlcUA(3′S)β1-3GalNAc(4S,6S)β1-) |
| HA462′3′ | (-GlcUA(2′S,3′S)β1-3GlcNAc(4S,6S)β1-) | CS462′3′ | (-GlcUA(2′S,3′S)β1-3GalNAc(4S,6S)β1-) |